SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India
13 references·1 citing·34 second hop
Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India (2019)Initial trends of individual donation nuc…Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Nucleic acid amplification te…Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan (2015)Impact of nucleic acid amplif…Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Automated nucleic acid amplif…Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)Screening Donated Blood for T…Epidemiological profile of seropositive blood donors at a tertiary care hospital in North India (2014)Epidemiological profile of se…A pilot study on screening blood donors with individual-donation nucleic acid testing in China. (2014)A pilot study on screening bl…Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi (2013)Transfusion transmittable inf…Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Nucleic acid testing for bloo…Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Need for Nucleic Acid Testing…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…Blood Donation Screening of Transfusion-Transmissible Viral Infection Using Two Different Nucleic Acid Testing (NAT) Platforms: A Single Tertiary Care Oncology Centre Experience (2022)Blood Donation Screening of T…The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Blood transfusion and hepatitis: what does it take to prevent new infections? (2018)Transfusion Transmissible Infections: Maximizing Donor Surveillance (2018)Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan (2023)Transfusion-transmitted infections (2007)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India (2016)Time Trend and Prevalence Analysis of Transfusion Transmitted Infections among Blood Donors: A Retrospective Study from 2001 to 2016 (2023)NAT of the United States and Canadian blood supply (2000)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Assessment of Blood Donation and Transfusion in Eastern Uganda: A Mixed-Methods Study (2019)High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Seven Years Experience in NAT Testing of Blood Donors in a Tertiary Care Centre (2019)Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers (2025)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited
  • 2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
  • 2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2014Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience44 cited
  • 2017Nucleic acid amplification testing in Indian blood banks: A review with perspectives39 cited
  • 2015Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety36 cited
  • 2015Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan29 cited
  • 2014A pilot study on screening blood donors with individual-donation nucleic acid testing in China.23 cited
  • 2013

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi
22 cited
  • 2014Epidemiological profile of seropositive blood donors at a tertiary care hospital in North India15 cited
  • Cited by

    • 2022Blood Donation Screening of Transfusion-Transmissible Viral Infection Using Two Different Nucleic Acid Testing (NAT) Platforms: A Single Tertiary Care Oncology Centre Experience6 cited